While gene therapy has great potential in the treatment of many diseases, a number of challenges lead to the slow progress of advancing gene therapy, as well as the safety of treatments. One of those challenges is the development of safe and effective viral vectors.
The adeno-associated virus (AAV) transduction application for the Emulate Liver-Chip co-culture helps to achieve faster vector optimization results. Learn more about the Liver-Chip co-culture and how it can accelerate the development of gene therapy vectors in a human-relevant liver model.
Learn more here